Features of Adipose Tissue Distribution in Patients with Diabetes Mellitus Type 2 with Obesity and Arterial Hypertension Associated with Dyslipidemia

K.O. Zuiev


Introduction. The development of atherogenic dyslipidemia in patients with diabetes mellitus (DM) type 2 and hypertension is an important risk factor for cardiovascular diseases and is often associated with obesity.
Objective. To examine the relationship between excess fat deposits in various compartments of the body and altered levels of blood lipids.
Materials and Methods. The study involved 53 patients (25 men) aged 55.90 ± 2.15 years with DM type 2, essential hypertension of stage I–II grade 2 and obesity of I–III degree (45 ≥ body mass index ≥ 30 kg/m2). In all patients we have determined plasma lipid levels and carried out a study of body structure using dual X-ray absorbtiometry with the determination total body fat (TBF) mass, android fat (AF) mass and gynoid fat (GF) mass. The regression analysis of the correlation between lipid profile parameters and fat mass based on its distribution has been carried out.
Results. Total cholesterol level was significantly associated with AF mass (r = 0.27; p = 0.04). Low-density lipoprotein cholesterol (LDL-cholesterol) level was positively associated with TBF (r = 0.34; p = 0.01). Herewith, the main contribution into this association was made by abdominal compartment, as the dependence of LDL-cholesterol on AF (r = 0.38) was statistically significant (p = 0.01). Triglyceride level was positively associated with TBF (r = 0.49; p = 0.001), as well as with AF (r = 0.39; p = 0.01) and GF (r = 0.32; p = 0.02). High-density lipoproteins (HDL) level was negatively associated with TBF (r = –0.36; p = 0.01).
Conclusions. In patients with DM type 2 with obesity and hypertension, the development of atherogenic dyslipidemia with elevated levels of total cholesterol, triglycerides and LDL-cholesterol, as well as with decreased level of HDL-cholesterol, is associated with an increase in the total amount of adipose tissue, and also with an excessive fat deposition in the abdominal region.


blood lipids; dual X-ray absorptiometry; diabetes mellitus type 2; hypertension; obesity


Farmer J.A. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials // Curr. Diab. Rep. — 2008. — 8. — Р. 71-77.

Куликова А.Н. Облитерирующий атеросклероз артерий нижних конечностей на фоне сахарного диабета 2-го типа / А.Н. Куликова // Международный эндокринологический журнал. — 2009. — № 2. — С. 109-115.

Després J.P., Lemieux I., Bergeron J. et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk // Arterioscler. Thromb. Vasc. Biol. — 2008. — 28. — Р. 1039-49.

Garvey W.T., Kwon S., Zheng D. et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance // Diabetes. — 2003. — 52. — Р. 453-462.

Kim Y.L., Kim T.K., Cheong E.S. et al. Relation of absolute or relative adiposity to insulin resistance, retinol binding protein-4, leptin, and adiponectin in type 2 diabetes // Diabetes Metab. J. — 2012. — 36. — Р. 415-21.

Albanese C.V., Diesel E., Genant H.K. A review: clinical application of body composition measurements using DXA // J. Clin. Densit. — 2003. — Vol. 6. — Р. 161-172.

Рекомендації Української Асоціації кардіологів з профілактики та лікування артеріальної гіпертензії. Посібник до Національної програми профілактики і лікування артеріальної гіпертензії. — К.: ПП ВМБ, 2008. — 80 с.

Perk J., De Backer G., Gohlke H. et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) // Eur. Heart J. — 2012. — 33(13). — P. 1635-1701.

European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z., Catapano A.L., De Backer G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) // Eur. Heart J. — 2011. — 32(14). — P. 1769-1818.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© "Publishing House "Zaslavsky", 1997-2020


   Seo анализ сайта